Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 30 October 2007
Vol. 2007, Issue 410, p. tw393
[DOI: 10.1126/stke.4102007tw393]


Development Need ADP to See

John F. Foley

Science’s STKE, AAAS, Washington, DC 20005, USA

Ectonucleoside triphosphate diphosphohydrolase 2 (E-NTPDase2) is a membrane-bound ectoenzyme that converts adenosine triphosphate (ATP) into adenosine diphosphate (ADP). In investigating roles for E-NTPDase2 in development, Massé et al. injected E-NTPDase2 mRNA into one side of a developing Xenopus laevis embryo and found ectopic eyelike structures on the injected side that were histologically characteristic of normal eyes. Pax6, Rx1, and Six3 encode eye-field transcription factors (EFTFs) that are responsible for eye development. Using in situ hybridization, the authors found that overexpression of E-NTPDase2 in injected embryos increased the expression of these EFTF genes. Knockdown of E-NTPDase2 by injection with a specific antisense morpholino oligonucleotide (MO) resulted in reduced expression of Pax6 compared with that in control MO-injected embryos, and knockdown of the ADP receptor P2Y1 had a synergistic effect on EFTF gene expression. Knockdown of both E-NTPDase2 and P2Y1 resulted in embryos with very small eyes, or even lacking an eye, on the injected side. Using a biosensor for ATP, transient production of ATP was detected in the anterior, but not posterior, neural plate at a time consistent with eye-field development; however, the cells responsible for releasing the ATP remain unknown. A P2Y1 antagonist blocked the effects of overexpression of E-NTPDase2, and a P2Y1 agonist rescued the effects of injection of an E-NTPDase2 MO. In humans, mutations in chromosome 9, where the gene locus of E-NTPDase2 is located, are associated with eye defects such as microphthalmia. This study suggests a mechanism whereby ADP signaling initiates development of the eye.

K. Massé, S. Bhamra, R. Eason, N. Dale, E. A. Jones, Purine-mediated signalling triggers eye development. Nature 449, 1058-1062 (2007). [PubMed]

Citation: J. F. Foley, Need ADP to See. Sci. STKE 2007, tw393 (2007).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882